Syndax Pharmaceuticals Inc (SNDX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	74.4	222.0	115.2	24.6	33.8	35.2	23.8	23.2
Short-term investments			177.8	35.2	47.1	94.8	81.5	63.3
Inventories			0.1	0.2	0.1	0.2	0.5	0.2
Other current assets	415.4	226.4	5.7	2.4	2.3	3.2	2.7	1.3
Total current assets	489.8	448.4	298.9	62.3	83.3	133.4	108.5	88.0
Property, plant, and equipment, net	0.0	0.3	0.2	0.3	0.4	0.3	0.3	0.1
Long-term investments						3.2
Other fixed assets	0.8		1.3	0.2	0.2	0.2	0.2	1.8
Total assets	497.2	449.7	300.6	63.5	83.9	137.2	109.0	89.9

Accounts payable	4.4	5.7	3.5	6.2	1.4	2.2	2.4	1.5
Accrued expenses	24.3	14.5	11.2	10.2	13.1	12.0	6.8	2.2
Short-term debt	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0
Short-term debt			2.3
Deferred revenues							1.2	1.2
Other current liabilities	0.4	0.5	1.8	2.0	1.5	1.6
Total current liabilities	29.1	20.7	18.9	18.4	16.1	15.8	10.4	4.8
Long-term debt			17.8
Other liabilities	0.7	20.6	11.7	13.6	14.8	17.1	14.5	18.4
Total liabilities	29.8	41.3	48.4	31.9	30.9	32.9	24.9	23.2

Shareholders' equity [+]	467.4	408.4	252.2	31.6	53.0	104.3	84.1	66.7
Paid-in capital	1,161.3	952.0	820.8	527.1	492.5	470.6	389.4
Retained earnings	-693.0	-543.7	-568.6	-495.5	-439.4	-366.1	-305.3	-259.7
Tangible shareholders' equity	467.4	408.4	252.2	31.6	53.0	104.3	84.1	66.7